/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

X

Xiaotian Zhang

Jiangnan University(CN)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

183

Papers

4.4K

Citations

38

h-index

90

i10-index

Xiaotian Zhang is an academic researcher from Jiangnan University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies. The author has an h-index of 38, co-authored 156 publications.

ORCID: 0000-0003-1134-0775

Research Topics

Cancer Immunotherapy and Biomarkers Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Genetic factors in colorectal cancer

Papers by this author

works

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

2022 · Nature Medicine · 527 citations

https://doi.org/10.1038/s41591-022-01800-8

Changsong Qi Jifang Gong Jian Li Dan Liu

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

2021 · Gastric Cancer · 140 citations

https://doi.org/10.1007/s10120-021-01168-7

Yingying Xu Yakun Wang Jifang Gong Xiaotian Zhang

Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma

2022 · BMC Medicine · 85 citations

https://doi.org/10.1186/s12916-022-02327-y

Zhenghang Wang Xinyu Wang Yu Xu Jian Li

Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer

2014 · Oncotarget · 77 citations

https://doi.org/10.18632/oncotarget.2175

Yilin Li Xiaotian Zhang Sai Ge Jing Gao

Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance

2018 · Clinical Cancer Research · 59 citations

https://doi.org/10.1158/1078-0432.ccr-18-1205

Yilin Li Xiaotian Zhang Dan Liu Jifang Gong

Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial

2024 · EClinicalMedicine · 58 citations

https://doi.org/10.1016/j.eclinm.2023.102415

Yakun Wang Jifang Gong Airong Wang Jia Wei

Research topics

topics

Cancer Immunotherapy and Biomarkers

Gastric Cancer Management and Outcomes

Colorectal Cancer Treatments and Studies

Cancer Genomics and Diagnostics

Genetic factors in colorectal cancer

Chat about Author

Papers

Chat

Click to start Chat